(function() { var x="https://ads.ehealthcaresolutions.com/c/?"+Math.random()*1e16; var y=document.createElement("script");y.type="text/javascript";y.async=true;y.src=x; var z=document.getElementsByTagName("script")[0]; z.parentNode.insertBefore(y, z); })();
Monday , June 18 2018
Home / Resources / Clinical Presentations / Pathophysiology in the Treatment of Type 2 Diabetes: Newer Agents, Part 2 of 5

Pathophysiology in the Treatment of Type 2 Diabetes: Newer Agents, Part 2 of 5

Sep 5, 2011
 

DCMS49_HS_Image 

This week we continue our series of Homerun Slides on Pathophysiology in the Treatment of Type 2 Diabetes: New Agents with information on Colesevelam….

Link to download (.ppt format): Pathophysiology in the Treatment of Type 2 Diabetes: New Agents, Part 2 of 5

Other sets in this series:

Pathophysiology in the Treatment of Type 2 Diabetes: Newer Agents, Part 1 of 5

Pathophysiology in the Treatment of Type 2 Diabetes: Newer Agents, Part 3 of 5

Pathophysiology in the Treatment of Type 2 Diabetes: Newer Agents, Part 4 of 5

Pathophysiology in the Treatment of Type 2 Diabetes: Newer Agents, Part 5 of 5

 

Check out all of Diabetes In Control’s slide collections at our new Clinical Presentations Library.